Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Gate2Brain will be attending The Investment Readiness Series

Events
Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.

On the 4th of July, Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland. The aim of the meeting is to put the best projects – from companies and/or research organizations –  in contact with investors, business angels, venture capitalists and leading Swiss companies.

This program that aims to increase the flow of projects ready to be invested in the BioRegion through private meetings with the most cutting-edge ecosystems in the world.

https://www.biocat.cat/en

 

April 26, 2022/by noticias
Tags: biocat, Biotech, science, Startup, technology
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/04/Boicot-2022.jpg 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-04-26 17:29:292022-04-26 17:29:29Gate2Brain will be attending The Investment Readiness Series
You might also like
CaixaImpuls Gate2Brain as alumni at Caixa Impulse Validate
VII SEQT Summer School “Medicinal Chemistry and Chemical Biology in Drug DiscoveryGate2Brain Gate2Brain at the VII SEQT Summer School
Nadia Calviño, First Vice President of the Government and Minister of Economic Affairs visits Gate2BrainSJD Nadia Calviño, First Vice President of the Government visits Gate2Brain
Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck
G2B receives funding to accelerate its transfer to the market and society
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient care Gate2Brain at MIT Pitch Day at University of Cambridge
BioSpain2021 Gate2Brain attending BioSpain 2021
EITHealth Catapult 2022eithealth Gate2Brain semifinalist of EITHealth’s Catapult 2022

CATEGORIES

  • Events
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • VII SEQT Summer School “Medicinal Chemistry and Chemical Biology in Drug DiscoveryGate2BrainGate2Brain at the VII SEQT Summer SchoolJuly 26, 2022 - 08:39
  • Thank you for inviting Gate2Brain last Friday to the conference "DIGITALIZING AND REINDUSTRIALIZING SPAIN WITH THE RECOVERY PLAN". The purpose of this conference, focused on the digital axis of the Recovery Plan, was to give visibility to some of the digitization projects that have already received funding from the Plan in different areas and that are already contributing to this transformation, as well as to present the evolution of the Digital Spain agenda.Asuntos Económicos y transformación digitalGate2Brain at “Digitalizing and reindustrializing Spain with the recovery plan”July 11, 2022 - 13:39
  • EITHealth Catapult 2022eithealthGate2Brain semifinalist of EITHealth’s Catapult 2022June 12, 2022 - 08:47
  • Gate2Brain will be attending in Basel, Switzerland, the Investment Readiness Series, a @Biocat initiative co-organized by the Delegation of the Government of Catalonia in Switzerland, The aim of the meeting is to put the best projects - from companies and/or research organizations - in contact with investors, business angels, venture capitalists and leading Swiss companies.Gate2Brain will be attending The Investment Readiness SeriesApril 26, 2022 - 17:29
  • Gate2Brain is delighted to be attending next week's #AseBioInvestorDay2022, organised by Asociación Española de Bioempresas in Madrid.Gate2BrainGate2Brain attending Asebio Investor Day 2022April 21, 2022 - 14:46

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • HIGHLIGHTS: Catalan health startups exceed 2021 investments during the first half of the year, unprecedented €100M mega-round, progress in advanced therapies, new equipment and acknowledgements July 28, 2022 biocat
  • 2021 Biocat Report of Activities: looking back on a historic time for the BioRegion July 26, 2022 biocat
  • Biocat, coordinator of two new European projects to maximize impact of innovation in BioRegion July 21, 2022 biocat
  • HIGHLIGHTS: the biggest funding round of the BioRegion, new scientific and hospital facilities, foreign investment in research, and collaborations with tech companies to improve health service provisions June 29, 2022 biocat
  • AseBio 2021 Report to highlight sector’s contribution to sustainable growth June 27, 2022 biocat
  • BioRegion pipeline and digital health firms catch eyes at BIO San Diego 2022 June 22, 2022 biocat
  • HIGHLIGHTS: BIOSPAIN in Barcelona, biggest round in digital health, new technical facilities, foreign investment in infrastructures and unbridled clinical trials activity May 25, 2022 biocat
  • Catalonia participates in over 1,200 active clinical trials May 17, 2022 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Many drugs do not reach the brain and Gate2Brain technology helps to overcome... Una tecnología para ayudar a tratar el cáncer infantilgate2brain A technology to help treat pediatric cancer
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}